The Institute for Innovation & Valuation in Health Care, InnoValHC, is an independent not-for-profit research organization. It was established by scientists with medical, health economic, and econometric backgrounds, as well as hands-on management experience, to analyze the economic dimension of health and health care, including research into the normative foundations and the methods of health economics, applied cost of illness and cost benefit studies, and their use in Health Technology Assessment (HTA).
Access to Rare and Complex Disease Therapies
Michael Schlander gave a presentation at the European Parliament in Brussels, Belgium, as part of the ´Health Leadership Mission for Rare Diseases´ (HLM4Rare) platform (July 01, 2026).
Heidelberg Health Economics Summer School 2026
The Heidelberg Health Economics Summer School Basic Module took place in the picturesque setting of the Italian Dolomites (Bruneck-Brunico, June 25-27, 2026).
German Cancer Congress (DKK) 2026
Michael Schlander was invited to contribute to the Highlight Session ´Socioeconomic Consequences of Cancer in Germany: The Perspective of Patients and their Relatives´ at the DKK in Berlin / Germany (Feb. 21, 2026).
Financing Health Care: Structural Challenges in Germany
Article published by Michael Schlander on structural challenges in health care financing and necessary reforms in the German health care system.
Read more … Financing Health Care: Structural Challenges in Germany
